Zoli W - Search Results

1

SLUG silencing increases radiosensitivity of melanoma cells in vitro.

Arienti C, Tesei A, Carloni S, Ulivi P, Romeo A, Ghigi G, Menghi E, Sarnelli A, Parisi E, Silvestrini R, Zoli W. Arienti C, et al. Among authors: zoli w. Cell Oncol (Dordr). 2013 Apr;36(2):131-9. doi: 10.1007/s13402-012-0120-6. Epub 2012 Dec 19. Cell Oncol (Dordr). 2013. PMID: 23250725

2

Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.

Vannini I, Bonafe M, Tesei A, Rosetti M, Fabbri F, Storci G, Ulivi P, Brigliadori G, Amadori D, Zoli W. Vannini I, et al. Among authors: zoli w. Cell Oncol. 2007;29(4):279-87. doi: 10.1155/2007/540821. Cell Oncol. 2007. PMID: 17641412 Free PMC article.

3

Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells.

Fabbri F, Amadori D, Carloni S, Brigliadori G, Tesei A, Ulivi P, Rosetti M, Vannini I, Arienti C, Zoli W, Silvestrini R. Fabbri F, et al. Among authors: zoli w. J Cell Physiol. 2008 Nov;217(2):494-501. doi: 10.1002/jcp.21522. J Cell Physiol. 2008. PMID: 18615564

4

Activity of lipoplatin in tumor and in normal cells in vitro.

Arienti C, Tesei A, Ravaioli A, Ratta M, Carloni S, Mangianti S, Ulivi P, Nicoletti S, Amadori D, Zoli W. Arienti C, et al. Among authors: zoli w. Anticancer Drugs. 2008 Nov;19(10):983-90. doi: 10.1097/CAD.0b013e3283114fb2. Anticancer Drugs. 2008. PMID: 18827563

5

Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.

Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W. Ulivi P, et al. Among authors: zoli w. J Cell Physiol. 2009 Jul;220(1):214-21. doi: 10.1002/jcp.21753. J Cell Physiol. 2009. PMID: 19288493

6

Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.

Arienti C, Zoli W, Pignatta S, Carloni S, Paganelli G, Ulivi P, Romeo A, Menghi E, Sarnelli A, Medri L, Polico R, Silvestrini R, Tesei A. Arienti C, et al. Among authors: zoli w. J Cell Physiol. 2014 Oct;229(10):1548-56. doi: 10.1002/jcp.24598. J Cell Physiol. 2014. PMID: 24591063

7

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Among authors: zoli w. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

8

p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.

Ulivi P, Zoli W, Calistri D, Fabbri F, Tesei A, Rosetti M, Mengozzi M, Amadori D. Ulivi P, et al. Among authors: zoli w. J Cell Physiol. 2006 Mar;206(3):611-5. doi: 10.1002/jcp.20503. J Cell Physiol. 2006. PMID: 16222700

9

Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.

Rosetti M, Zoli W, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Granato AM, Amadori D, Silvestrini R. Rosetti M, et al. Among authors: zoli w. J Cell Physiol. 2007 Sep;212(3):710-6. doi: 10.1002/jcp.21067. J Cell Physiol. 2007. PMID: 17458894

10

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.

Tesei A, Rosetti M, Ulivi P, Fabbri F, Medri L, Vannini I, Bolla M, Amadori D, Zoli W. Tesei A, et al. Among authors: zoli w. J Transl Med. 2007 Oct 30;5:52. doi: 10.1186/1479-5876-5-52. J Transl Med. 2007. PMID: 17971198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters